Furthermore, Triciribine (TCN), a selective Akt inhibitor, significantly reduced the expression of phosphorylated Akt, HIF–1α, and survivin in human gastric cancer cells under hypoxic conditions [22]. This evidence concerns the gene AKT1 and gastric cancer.